Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001048477-25-000011
Filing Date
2025-02-26
Accepted
2025-02-26 16:14:30
Documents
3
Period of Report
2025-02-24

Document Format Files

Seq Description Document Type Size
1 FORM 3 wk-form3_1740604461.html 3  
1 FORM 3 wk-form3_1740604461.xml 3 1606
2 EX-24 section16filingspowerofa.htm EX-24 4156
3 section16filingspowerofa001.jpg GRAPHIC 239910
  Complete submission text file 0001048477-25-000011.txt   337649
Mailing Address 105 DIGITAL DRIVE NOVATO CA 94949
Business Address 105 DIGITAL DRIVE NOVATO CA 94949 4155066700
BIOMARIN PHARMACEUTICAL INC (Issuer) CIK: 0001048477 (see all company filings)

EIN.: 680397820 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 308 COURTLAND AVE PARK RIDGE IL 60068
Business Address
Walbert Timothy P (Reporting) CIK: 0001349376 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-26727 | Film No.: 25670204